About Bryant Godfrey

Bryant Godfrey is a partner at Foley Hoag and co-chair of the healthcare department and the FDA practice group. He provides strategic regulatory advice to pharmaceutical, medical device and biotech companies, helping them to navigate challenges relating to the development, manufacturing, approval and promotion of drugs, biologics, medical devices and combination products. Having spent nearly a decade at the US Food and Drug Administration in senior regulatory and policy roles, he has extensive experience, including in issues relating to advertising and promotion, scientific exchange, investigations of off-label marketing, product jurisdiction, labelling, and post-marketing commitments and requirements.